Goldman Sachs
CTNM

Goldman Sachs’s Contineum Therapeutics CTNM Stock Holding History

Goldman Sachs’s Portfolio CTNM Stock Details CTNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$242K Buy
60,922
+46,701
+328% +$185K ﹤0.01% 4635
2025
Q1 		$99.3K Sell
14,221
-12,144
-46% -$84.8K ﹤0.01% 4820
2024
Q4 		$386K Buy
+26,365
New +$386K ﹤0.01% 4421